Lung cancer treatments in the era of personalized medicine
Using an individual patient's genetic code helps doctors select treatments most likely to be effective, and that includes for lung cancers, some of the deadliest types of cancer. Using an individual…
Read the full articleYou might also wanna read
Expert Panel Discussion on Personalized Decision-Making for HER2-Mutated NSCLC
Get the latest updates on HER2-mutated NSCLC.
mdsc.pe·1d agoDocWire News: The Role of Genomic Assays in Personalizing Treatment for Early HR+ Breast Cancer
The post DocWire News: The Role of Genomic Assays in Personalizing Treatment for Early HR+ Breast Cancer appeared first on UNC Lineberger Co
How machine learning is advancing precision medicine and pharmacogenomics
Machine learning has unlocked significant value across the entire healthcare delivery lifecycle.
forbes.com·19d agoComprehensive Genomic Profiling Delays in Lung Cancer: Biopsy-to-Order Time Remains the Biggest Barrier
Comprehensive genomic profiling has changed lung cancer care. But a new analysis in JCO Oncology Practice shows that many patients still wai
Catalysts for Care: How Visionary Doctors are Driving Lung Cancer Screening Success
Each year lung cancer claims more lives than breast, cervical, and colon cancers combined. As the leading cause of cancer deaths worldwide,
From Bench to Bedside: Non-Small Cell Lung Cancer Discovery Creates Hope
Afshin Dowlait, MD describes how his team of researchers discovered a new non-small cell lung cancer subtype in the laboratory and brought a
Comments
Sign in to join the conversation.
No comments yet. Be the first.